Omeprazole
DrugOther names: Losec
NCT Number: NCT00641264
The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that were evaluated were: validity, reliability, and responsiveness to change (as a measure of treatment effect).
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Losec
Time frame: 2 monthly
Time frame: 2 monthly
AstraZeneca
Industry
Laryngopharyngeal Reflux Health Related Quality of Life (LPR-HRQL) Questionnaire Development and Psychometric Testing in Patients Receiving Omeprazole 20 mg Bid as Treatment for Laryngopharyngeal Reflux.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01755221
Deglutition Disorders, Digestive System Diseases
Chicago, Illinois, United States
View Trial DetailsNCT04771221
Deglutition Disorders, Digestive System Diseases
Almaty, Kazakhstan
View Trial DetailsNCT05296655
Deglutition Disorders, Digestive System Diseases
Almaty, Kazakhstan
View Trial DetailsNCT07696429
Deglutition Disorders, Digestive System Diseases
Zagreb, Croatia
View Trial Details